OWA
CPRX

One Wealth Advisors’s Catalyst Pharmaceutical CPRX Stock Holding History

One Wealth Advisors’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-22,008
Closed -$149K – 207
2021
Q4 		$149K Hold
22,008
– – 0.04% 193
2021
Q3 		$117K Hold
22,008
– – 0.03% 211
2021
Q2 		$127K Buy
22,008
+166
+0.8% +$857 0.04% 173
2021
Q1 		$101K Buy
+21,842
New +$86.8K 0.04% 156

Other funds holding CPRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

One Wealth Advisors's CPRX Position: Q1 2022 in Review

One Wealth Advisors sold out of Catalyst Pharmaceutical (CPRX) in Q1 2022, closing a stake of 22,008 shares — an estimated $149K sold.

One Wealth Advisors first reported a position in CPRX in Q1 2021 and held it in 4 quarters. The position peaked at $149K in Q4 2021. 187 funds tracked by Wall St. Rank hold CPRX as of Q1 2022.

  • One Wealth Advisors reported no remaining Catalyst Pharmaceutical position as of Q1 2022 after selling out during the quarter.
  • One Wealth Advisors sold 22,008 Catalyst Pharmaceutical shares in Q1 2022, an estimated $149K.
  • One Wealth Advisors first reported a position in Catalyst Pharmaceutical in Q1 2021 and held it in 4 quarters.
  • One Wealth Advisors's Catalyst Pharmaceutical position peaked at $149K in Q4 2021.
  • 187 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2022.

Based on One Wealth Advisors's 13F filing for Q1 2022, filed 16 May 2022.